-transparent.png){kind=logo}
Thirty-eight patients with small cell carcinoma of the bronchus resistant to initial chemotherapy with cyclophosphamide methotrexate and CCNU, were treated with VP16-213 alone in a dose of 120 mg/m2 i.v. on days 1, 3, and 5 every 3 weeks. Twelve patients died before three courses of treatment. In 26 patients who received three or more courses only one, transient partial response occurred. One or more components of the initial chemotherapy seems to confer resistance to the action of VP16-213 in this disease.
Related Publications
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
January 1985,
Haematology and blood transfusion,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
May 1982,
International journal of radiation oncology, biology, physics,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
January 1982,
Cancer chemotherapy and pharmacology,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
December 1994,
Acta paediatrica (Oslo, Norway : 1992),
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
April 1982,
European journal of cancer & clinical oncology,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
January 1982,
Cancer chemotherapy and pharmacology,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
January 1982,
Cancer chemotherapy and pharmacology,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
January 1982,
Cancer chemotherapy and pharmacology,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
May 1989,
Respiratory medicine,
P G Harper, and
M B Dally, and
D M Geddes, and
S G Spiro, and
J F Smyth, and
R L Souhami
January 1982,
Cancer chemotherapy and pharmacology,
